{"DataElement":{"publicId":"2646748","version":"1","preferredName":"NCCTG Patient N063D Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of characteristics in N063D protocol, any one of which may exclude a potential subject from participation in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NCCTG_O63D_E_CTEC_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2646745","version":"1","preferredName":"NCCTG Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information related list of characteristics in a protocol, any one of which may exclude a potential subject from participation in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NCCTG_PT_E_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2646707","version":"1","preferredName":"North Central Cancer Treatment Group Patient","preferredDefinition":"The North Central Cancer Treatment Group (NCCTG) is a national clinical research group sponsored by the NCI. The research base for NCCTG is located at Mayo Clinic in Rochester, Minn. NCCTG consists of a network of more than 1,000 cancer specialists at community clinics, hospitals and medical centers in 25 states in US, two Canadian provinces and Mexico. NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer treatments.:A person who requires medical care.","longName":"C25581:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"North Central Cancer Treatment Group","conceptCode":"C25581","definition":"A national clinical research group sponsored by the NCI. The research base for NCCTG is located at Mayo Clinic in Rochester, Minn. NCCTG consists of a network of more than 1,000 cancer specialists at community clinics, hospitals and medical centers in 25 states in US, two Canadian provinces and Mexico. NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer treatments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A1EC6-A8FA-1E06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3219FBA1-0F78-3427-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646746","version":"1","preferredName":"N063D Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of exclusion clinical trial eligibility criteria for NCCTG N063D protocol.","longName":"N063D_E_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"History of any prior (ipsi- and/or contralateral) invasive breast carcinoma","valueDescription":"History of any prior (ipsi- and/or contralateral) invasive breast carcinoma","ValueMeaning":{"publicId":"2646749","version":"1","preferredName":"History of any prior (ipsi- and/or contralateral) invasive breast carcinoma","longName":"2646749","preferredDefinition":"History of any prior (ipsi- and/or contralateral) invasive breast carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B13A6-A18A-38B3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B23C5-7FD5-33C8-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin or carcinoma in situ of the cervix","valueDescription":"Past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin or carcinoma in situ of the cervix","ValueMeaning":{"publicId":"2646750","version":"1","preferredName":"Past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin or carcinoma in situ of the cervix","longName":"2646750","preferredDefinition":"Past or current history of malignant neoplasms, except for curatively treated basal and squamous cell carcinoma of the skin or carcinoma in situ of the cervix","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B1DCE-8C29-39CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B23C5-7FE7-33C8-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Any clinically staged T4 tumor, including inflammatory breast cancer","valueDescription":"Any clinically staged T4 tumor, including inflammatory breast cancer","ValueMeaning":{"publicId":"2646751","version":"1","preferredName":"Any clinically staged T4 tumor, including inflammatory breast cancer","longName":"2646751","preferredDefinition":"Any clinically staged T4 tumor, including inflammatory breast cancer;","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B2185-2498-3A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B23C5-7FF9-33C8-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Bilateral tumors","valueDescription":"Bilateral tumors","ValueMeaning":{"publicId":"2646752","version":"1","preferredName":"Bilateral tumors","longName":"2646752","preferredDefinition":"Bilateral tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B25CE-4792-3881-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B2D65-7AE0-3AD6-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Multifocal tumors","valueDescription":"Multifocal tumors","ValueMeaning":{"publicId":"2646753","version":"1","preferredName":"Multifocal tumors","longName":"2646753","preferredDefinition":"Multifocal tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B13A6-A19A-38B3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B2D65-7AF2-3AD6-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Maximum cumulative dose of doxorubicin >360mg/m2 or maximum cumulative dose of epirubicin >720mg/m2 or any prior anthracyclines unrelated to the present breast cancer","valueDescription":"Maximum cumulative dose of doxorubicin >360mg/m2 or maximum cumulative dose of epirubicin >720mg/m2 or any prior anthracyclines unrelated to the present breast cancer","ValueMeaning":{"publicId":"2646754","version":"1","preferredName":"Maximum cumulative dose of doxorubicin >360mg/m2 or maximum cumulative dose of epirubicin >720mg/m2 or any prior anthracyclines unrelated to the present breast cancer","longName":"2646754","preferredDefinition":"Maximum cumulative dose of doxorubicin >360mg/m2 or maximum cumulative dose of epirubicin >720mg/m2 or any prior anthracyclines unrelated to the present breast cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B1668-6B83-3906-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B2D65-7B04-3AD6-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"(Neo-) or adjuvant chemotherapy using peripheral stem cell or bone marrow stem cell support","valueDescription":"(Neo-) or adjuvant chemotherapy using peripheral stem cell or bone marrow stem cell support","ValueMeaning":{"publicId":"2646755","version":"1","preferredName":"(Neo-) or adjuvant chemotherapy using peripheral stem cell or bone marrow stem cell support","longName":"2646755","preferredDefinition":"(Neo-) or adjuvant chemotherapy using peripheral stem cell or bone marrow stem cell support","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B3A68-1469-3D12-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B13A6-A1B1-38B3-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Any prior mediastinal irradiation except internal mammary node irradiation for the present","valueDescription":"Any prior mediastinal irradiation except internal mammary node irradiation for the present breast cancer","ValueMeaning":{"publicId":"2646756","version":"1","preferredName":"Any prior mediastinal irradiation except internal mammary node irradiation for the present breast cancer","longName":"2646756","preferredDefinition":"Any prior mediastinal irradiation except internal mammary node irradiation for the present breast cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B2185-24A8-3A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B2185-24BF-3A35-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Patients with positive or suspicious internal mammary nodes identified by sentinel node technique which have not been irradiated or will not be irradiated, or patients with supraclavicular lymph node involvement","valueDescription":"Patients with positive or suspicious internal mammary nodes identified by sentinel node technique which have not been irradiated or will not be irradiated, or patients with supraclavicular lymph node involvement","ValueMeaning":{"publicId":"2646757","version":"1","preferredName":"Patients with positive or suspicious internal mammary nodes identified by sentinel node technique which have not been irradiated or will not be irradiated, or patients with supraclavicular lymph node involvement","longName":"2646757","preferredDefinition":"Patients with positive or suspicious internal mammary nodes identified by sentinel node technique which have not been irradiated or will not be irradiated, or patients with supraclavicular lymph node involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B4D40-50D0-3AFC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3219E8EB-1B38-33D6-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for breast cancer","valueDescription":"Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for breast cancer","ValueMeaning":{"publicId":"2646758","version":"1","preferredName":"Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for breast cancer","longName":"2646758","preferredDefinition":"Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for breast cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B5169-247A-33D2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B2185-24D1-3A35-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Concurrent anti-cancer treatment, except hormonal therapy","valueDescription":"Concurrent anti-cancer treatment, except hormonal therapy","ValueMeaning":{"publicId":"2646759","version":"1","preferredName":"Concurrent anti-cancer treatment, except hormonal therapy","longName":"2646759","preferredDefinition":"Concurrent anti-cancer treatment, except hormonal therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B5426-F230-33D0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B5521-59CA-3950-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Concurrent anti-cancer treatment in another investigational trial with hormone therapy or immunotherapy","valueDescription":"Concurrent anti-cancer treatment in another investigational trial with hormone therapy or immunotherapy","ValueMeaning":{"publicId":"2646760","version":"1","preferredName":"Concurrent anti-cancer treatment in another investigational trial with hormone therapy or immunotherapy","longName":"2646760","preferredDefinition":"Concurrent anti-cancer treatment in another investigational trial with hormone therapy or immunotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B25CE-47A2-3881-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3219E8EB-1B4A-33D6-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Serious cardiac illness or medical conditions (including...)","valueDescription":"Serious cardiac illness or medical conditions","ValueMeaning":{"publicId":"2646761","version":"1","preferredName":"Serious cardiac illness or medical conditions","longName":"2646761","preferredDefinition":"Serious cardiac illness or medical conditions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A88B9-0CF2-397E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A89DA-0A43-44AF-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Other concurrent serious diseases that may interfere with planned treatment including severe pulmonary conditions/illness","valueDescription":"Other concurrent serious diseases that may interfere with planned treatment including severe pulmonary conditions/illness","ValueMeaning":{"publicId":"2646762","version":"1","preferredName":"Other concurrent serious diseases that may interfere with planned treatment including severe pulmonary conditions/illness","longName":"2646762","preferredDefinition":"Other concurrent serious diseases that may interfere with planned treatment including severe pulmonary conditions/illness","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A8C81-4229-44CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A8D0F-6FEB-3433-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Any of the following abnormal laboratory tests immediately prior to randomization (see list in instructions)","valueDescription":"Any of the following abnormal laboratory tests immediately prior to randomization","ValueMeaning":{"publicId":"2646763","version":"1","preferredName":"Any of the following abnormal laboratory tests immediately prior to randomization","longName":"2646763","preferredDefinition":"Any of the following abnormal laboratory tests immediately prior to randomization","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A8D0F-6FF6-3433-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A94C6-9FF9-447C-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ALAIS","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Unresolved or unstable serious adverse event from prior adjuvant chemotherapy or radiotherapy","valueDescription":"Unresolved or unstable serious adverse event from prior adjuvant chemotherapy or radiotherapy","ValueMeaning":{"publicId":"2646764","version":"1","preferredName":"Unresolved or unstable serious adverse event from prior adjuvant chemotherapy or radiotherapy","longName":"2646764","preferredDefinition":"Unresolved or unstable serious adverse event from prior adjuvant chemotherapy or radiotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A9920-570B-464A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B5521-59DC-3950-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, or person unable to swallow oral medication","valueDescription":"Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, or person unable to swallow oral medication","ValueMeaning":{"publicId":"2646765","version":"1","preferredName":"Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, or person unable to swallow oral medication","longName":"2646765","preferredDefinition":"Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, or person unable to swallow oral medication","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B2185-24DC-3A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A9F55-A8DA-39BC-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Pregnant or lactating women","valueDescription":"Pregnant or lactating women","ValueMeaning":{"publicId":"2646766","version":"1","preferredName":"Pregnant or lactating women","longName":"2646766","preferredDefinition":"Pregnant or lactating women","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A968E-68BF-4610-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B5521-59EE-3950-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Women of childbearing potential including women whose last menstrual period was <1 year ago who are unable or unwilling to use adequate contraceptive measures during study treatment","valueDescription":"Women of childbearing potential including women whose last menstrual period was <1 year ago who are unable or unwilling to use adequate contraceptive measures during study treatment","ValueMeaning":{"publicId":"2646767","version":"1","preferredName":"Women of childbearing potential including women whose last menstrual period was <1 year ago who are unable or unwilling to use adequate contraceptive measures during study treatment","longName":"2646767","preferredDefinition":"Women of childbearing potential including women whose last menstrual period was <1 year ago who are unable or unwilling to use adequate contraceptive measures during study treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A9F55-A8E5-39BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321B5521-5A00-3950-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Concomitant use of CYP3A4 inhibitors or inducers","valueDescription":"Concomitant use of CYP3A4 inhibitors or inducers","ValueMeaning":{"publicId":"2646768","version":"1","preferredName":"Concomitant use of CYP3A4 inhibitors or inducers","longName":"2646768","preferredDefinition":"Concomitant use of CYP3A4 inhibitors or inducers","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321AA9C2-B798-33E8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321AA9C2-B7AF-33E8-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B0289-96DE-3652-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"321B0F7C-68F8-384B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}